{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/haematological-cancers-recognition-referral/diagnosis/symptoms-suggestive-of-haematological-cancers/","result":{"pageContext":{"chapter":{"id":"399985ab-242f-53f8-8852-45b946548d09","slug":"symptoms-suggestive-of-haematological-cancers","fullItemName":"Symptoms suggestive of haematological cancers","depth":2,"htmlHeader":"<!-- begin field a8a49531-5732-40ab-b341-abed4fde3c3e --><h2>Symptoms suggestive of haematological cancers</h2><!-- end field a8a49531-5732-40ab-b341-abed4fde3c3e -->","summary":"","htmlStringContent":"<!-- begin item 61d5073c-1b3d-4d1b-bc02-9a1961648849 --><!-- begin field 879b5e59-e0be-4727-af90-b63ec2e2f4d9 --><p><strong>Table 2</strong><strong>. </strong>Symptoms suggestive of haematological cancers.</p><table data-table-id=\"ad37c456-1468-4489-a8f1-acce014f9cab\"><thead><tr><th><p>Symptom</p></th><th><p>Possible cancer</p></th><th><p>Referral recommendation</p></th></tr></thead><tbody><tr><td>Alcohol-induced lymph node pain with unexplained lymphadenopathy in adults</td><td>Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Back pain (persistent), 60 years and over</td><td>Myeloma</td><td>Offer a full blood count, blood tests for calcium and plasma viscosity or erythrocyte sedimentation rate</td></tr><tr><td>Bleeding or bruising (unexplained) in children and young people</td><td>Leukaemia</td><td>Offer a very urgent full blood count (within 48 hours)</td></tr><tr><td>Bone pain (persistent or unexplained) in children and young people</td><td>Leukaemia</td><td>Offer a very urgent full blood count (within 48 hours)</td></tr><tr><td>Bone pain (persistent), 60 years and over</td><td>Myeloma</td><td>Offer a full blood count, blood tests for calcium and plasma viscosity or erythrocyte sedimentation rate to assess for myeloma</td></tr><tr><td>Bruising (unexplained) in adults</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Bruising, bleeding, or petechiae (unexplained)</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Fatigue (persistent) in adults</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Fatigue (persistent) in children and young people</td><td>Leukaemia</td><td>Offer a very urgent full blood count (within 48 hours)</td></tr><tr><td>Fever (unexplained)</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Fever (unexplained) in children and young people</td><td>Leukaemia</td><td>Offer a very urgent full blood count (within 48 hours)</td></tr><tr><td>Fever with lymphadenopathy (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms</td></tr><tr><td>Fever with splenomegaly (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms</td></tr><tr><td>Fever with unexplained lymphadenopathy in adults</td><td>Hodgkin's lymphoma or non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Fever with unexplained splenomegaly in adults</td><td>Non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Fracture (unexplained), 60 years and over</td><td>Myeloma</td><td>Offer a full blood count, blood tests for calcium and plasma viscosity or erythrocyte sedimentation rate</td></tr><tr><td>Hepatosplenomegaly in adults</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Hepatosplenomegaly (unexplained) in children and young people</td><td>Leukaemia</td><td>Refer for immediate specialist assessment</td></tr><tr><td>Infection (unexplained and persistent or recurrent) in adults</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Infection (unexplained and persistent) in children and young people</td><td>Leukaemia</td><td>Offer a very urgent full blood count (within 48 hours)</td></tr><tr><td>Lymphadenopathy (generalised) in adults</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Lymphadenopathy (generalised) in children and young people</td><td>Leukaemia</td><td>Offer a very urgent full blood count (within 48 hours)</td></tr><tr><td>Lymphadenopathy (unexplained) in adults</td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td><p>Consider a suspected cancer pathway referral (for an appointment within 2 weeks)</p><p>When considering referral for Hodgkin's lymphoma, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, weight loss, or alcohol-induced lymph node pain</p><p>When considering referral for non-Hodgkin's lymphoma, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, or weight loss</p></td></tr><tr><td>Lymphadenopathy (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td><p>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, or weight loss</p></td></tr><tr><td>Night sweats with lymphadenopathy (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td><p>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms</p></td></tr><tr><td>Night sweats with splenomegaly (unexplained) in children and young people</td><td>Non-Hodgkin's lymphoma</td><td><p>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms</p></td></tr><tr><td>Night sweats with unexplained lymphadenopathy in adults</td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td><p>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</p></td></tr><tr><td>Night sweats with unexplained splenomegaly in adults</td><td>Non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Pallor in adults</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Pallor in children and young people</td><td>Leukaemia</td><td>Offer a very urgent full blood count (within 48 hours)</td></tr><tr><td>Parental or carer insight, concern, or anxiety about the child's or young person's symptoms (persistent)</td><td>Childhood cancer</td><td><p>Take into account the insight and knowledge of parents and carers when considering making a referral for suspected cancer in a child or young person</p><p>Consider referral for children if their parent or carer has persistent concern or anxiety about the child's symptoms, even if the symptoms are most likely to have a benign cause</p></td></tr><tr><td>Petechiae (unexplained) in adults</td><td>Leukaemia</td><td>Consider a very urgent full blood count (within 48 hours)</td></tr><tr><td>Petechiae (unexplained) in children and young people</td><td>Leukaemia</td><td>Refer for immediate specialist assessment</td></tr><tr><td>Pruritus with lymphadenopathy (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms</td></tr><tr><td>Pruritus with splenomegaly (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms.</td></tr><tr><td>Pruritus with unexplained lymphadenopathy in adults</td><td>Hodgkin's lymphoma or non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Pruritus with unexplained splenomegaly in adults</td><td>Non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Shortness of breath with lymphadenopathy in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms</td></tr><tr><td>Shortness of breath with splenomegaly (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms</td></tr><tr><td>Shortness of breath with unexplained lymphadenopathy in adults</td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Shortness of breath with unexplained splenomegaly in adults<sup>1</sup></td><td>Non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Splenomegaly (unexplained) in adults</td><td>Non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, or weight loss</td></tr><tr><td>Splenomegaly (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, or weight loss</td></tr><tr><td>Weight loss with lymphadenopathy (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma or Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment in children and young people. When considering referral, take into account any associated symptoms</td></tr><tr><td>Weight loss with splenomegaly (unexplained) in children and young people<sup>1</sup></td><td>Non-Hodgkin's lymphoma</td><td>Consider a very urgent referral (for an appointment within 48 hours) for specialist assessment. When considering referral, take into account any associated symptoms</td></tr><tr><td>Weight loss with unexplained lymphadenopathy in adults</td><td>Hodgkin's lymphoma or non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td>Weight loss with unexplained splenomegaly in adults<sup>1</sup></td><td>Non-Hodgkin's lymphoma</td><td>Consider a suspected cancer pathway referral (for an appointment within 2 weeks). When considering referral, take into account any associated symptoms</td></tr><tr><td colspan=\"3\"><sup>1</sup>Separate recommendations have been made for adults and for children and young people to reflect that there are different referral pathways. However, in practice young people (aged 16–24 years) may be referred using either an adult or children's pathway depending on their age and local arrangements</td></tr><tr><td colspan=\"3\"><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/haematological-cancers-recognition-referral/references/\">NICE, 2015</a>]</td></tr></tbody></table><!-- end field 879b5e59-e0be-4727-af90-b63ec2e2f4d9 --><!-- end item 61d5073c-1b3d-4d1b-bc02-9a1961648849 -->","topic":{"id":"7a666688-628e-59c5-9e49-275e6df96c89","topicId":"efd78d5c-f39b-47aa-a99a-712fcd440511","topicName":"Haematological cancers - recognition and referral","slug":"haematological-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"1b99cc60-959f-5937-a54d-248dd557eb06","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"f3b3ad5d-37b7-5a29-8e71-51338dfd53d0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"77a57871-2fdc-584c-9148-924a40f28c72","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1b4978ef-a636-510a-b98b-df2c1d638607","slug":"changes","fullItemName":"Changes"},{"id":"31156ad7-e1ac-50f7-a238-d5ab91d07500","slug":"update","fullItemName":"Update"}]},{"id":"dfef533d-7728-5775-8f82-3e745c90c505","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"388024d8-7d15-587b-8988-d7c628863b80","slug":"goals","fullItemName":"Goals"},{"id":"c513e6cc-f297-57a6-adef-8b1e4f1f8f2c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"7e3cb3e7-e51c-5962-8394-f4e0a6813935","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"3aaac357-49bc-50e7-9bc7-f68a75f8f23b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f422ee8f-401a-55f0-af2e-ec46fece5aba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7a906314-79dc-5a14-86d9-f6c963dbfaf0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0205c796-921c-5df9-aa6e-52892106204f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"0075cdde-2c8e-5e7d-9734-e640651b657b","slug":"presentation","fullItemName":"Presentation"},{"id":"76cd470e-5904-5537-8ec0-73d5a2425747","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0fbae03d-8109-54c7-ad40-6ad26a3ae1b4","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"f824311f-b5dd-585e-bda3-3f418f0cd768","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"399985ab-242f-53f8-8852-45b946548d09","slug":"symptoms-suggestive-of-haematological-cancers","fullItemName":"Symptoms suggestive of haematological cancers"},{"id":"129bfa10-e11b-5bf8-aeac-2ec5de9171d7","slug":"investigations-in-primary-care","fullItemName":"Investigations in primary care"}]},{"id":"e4e9d509-0950-59c5-9f10-397475616fe8","fullItemName":"Management","slug":"management","subChapters":[{"id":"cfe47d3f-300b-5be4-b4da-3dd966fef722","slug":"referral-for-haematological-cancer","fullItemName":"Scenario: Referral for haematological cancer"}]},{"id":"61fcee5d-ff66-5a4c-91e7-4f497dfcc559","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ae7d0bdc-fc33-577f-9cfe-009a08676afa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f9e3a44b-54f7-5761-b0f1-43617129d77e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"13a9be84-5d20-5ab3-8ea3-6490e30776d4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e1c7b25a-a475-5f05-a2da-9d859d501051","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f9ed371b-e3f7-510a-a3f5-e7c55990b468","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ff05ddf2-8028-5120-8912-94378fd8dc5a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f7896863-2653-51f8-8deb-f8525add21d6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"f824311f-b5dd-585e-bda3-3f418f0cd768","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"d9b0597e-8418-5029-aeff-f0de4041f5bb","slug":"basis-for-recommendation-4c0","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 563c4718-4c7c-46c4-b829-b504cee45e68 --><h3>Basis for recommendation</h3><!-- end field 563c4718-4c7c-46c4-b829-b504cee45e68 -->","summary":null,"htmlStringContent":"<!-- begin item 4c0191f1-d5d3-4dc7-844c-27b1becb52a4 --><!-- begin field 98876feb-dda9-4f36-80bb-53937c2baf9e --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/haematological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 98876feb-dda9-4f36-80bb-53937c2baf9e --><!-- end item 4c0191f1-d5d3-4dc7-844c-27b1becb52a4 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}